JNJ-61393215
- Generic Name
- JNJ-61393215
A Study of JNJ-61393215 in Healthy Japanese Male Participants
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2025-04-28
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 24
- Registration Number
- NCT04713930
- Locations
- π―π΅
Souseikai Hakata Clinic, Fukuoka, Japan
A Study of JNJ-61393215 in the Treatment of Depression
Phase 2
Completed
- Conditions
- Major Depressive Disorder With Anxious Distress
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 222
- Registration Number
- NCT04080752
- Locations
- πΊπ¦
MNCE of Kyiv RC Regional Psychiatric and Narcological Medical Association, Glevakha, Ukraine
πΊπΈCollaborative NeuroScience Network, Garden Grove, California, United States
πΊπΈAtlanta Institute, Alpharetta, Georgia, United States
A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy Participants
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 57
- Registration Number
- NCT03649997
- Locations
- π³π±
PRA Health Sciences, Groningen, Netherlands
A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT03593954
- Locations
- πΊπΈ
PRA International, Salt Lake City, Utah, United States
A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 71
- Registration Number
- NCT03007693
Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy Participants
- First Posted Date
- 2016-06-24
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen-Cilag International NV
- Target Recruit Count
- 80
- Registration Number
- NCT02812251
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath